Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2025

Aug 15, 2025

34129_dirs_2025-08-15_3e48de07-0f72-4675-a536-c954b51d083c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2025-08-13

Reporting Person: Koenig Scott (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-08-13 Common Stock M 21165 Acquired 798580 Direct
2025-08-13 Common Stock M 31664 Acquired 830244 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-08-13 Restricted Stock Unit $0 M 21165 Disposed Common Stock (21165) Direct
2025-08-13 Restricted Stock Unit $0 M 31664 Disposed Common Stock (31664) Direct

Footnotes

F1: Pursuant to the Separation and Consulting Agreement between the Company and the Reporting Person (the "Separation Agreement"), 50% of the shares with respect to each outstanding and unvested restricted stock unit (RSU) immediately vested. Vested shares will be delivered to the Reporting Person as soon as practicable after the date of vesting.

F2: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.